GLP1R and diabetic retinopathy: GLP1 receptor agonists (e.g., semaglutide) are debated for diabetic retinopathy due to paradoxical effects, because the early worsening of retinopathy has been observed in some patients, possibly tied to rapid glycemic control [236].